Dutetrabenazine: Completed Phase III enrollment

Auspex completed enrollment of 90 HD patients who have not previously taken tetrabenazine in the double-blind, placebo-controlled, North American Phase III First-HD trial evaluating 6, 9 and 12 mg ora...